Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon



  1. Lee CC, Lin JC, Hwang WL, Kuo YJ, Chen HK, Tai SK, Lin CC, Yang MH*.  Macrophage-Secreted Interleukin-35 Regulates Cancer Cell Plasticity to Facilitate Metastatic Colonization. Nat Commun 2018 Sep; 9(1): 3763. (IF: 12.353; Multidisciplinary Sciences 3/64)

  2. Pan YR, Chen CC, Chan YT, Wang HJ, Chien FT, Chen YL, Liu JL, Yang MH*.  STAT3-coordinated Migration Facilitates the Dissemination of Diffuse Large B-cell Lymphomas. Nat Commun 2018 Sep; 9(1): 3696. (IF: 12.353; Multidisciplinary Sciences 3/64)

  3. Goss G*, Tsai CM, Shepherd FA, Ahn MJ, Bazhenova L, Crino L, de Marinis F, Felip E, Morabito A, Hodge R, Cantarini M, Johnson M, Mitsudomi T, Janne PA, Yang JC.  CNS Response to Osimertinib in Patients with T790M-Positive Advanced NSCLC: Pooled Data from Two Phase II Trials. Ann Oncol 2018 Mar; 29(3): 687-93. Epub 2017 Dec. (IF: 11.855; Oncology 10/217)

  4. Cortes J*, Perez-Garcia J, Levy C, Gomez Pardo P, Bourgeois H, Spazzapan S, Martinez-Janez N, Chao TC, Espie M, Nabholtz JM, Gonzalez Farre X, Beliakouski V, Roman Garcia J, Holgado E, Campone M.  Open-Label Randomised Phase III Trial of Vinflunine Versus an Alkylating Agent in Patients with Heavily Pretreated Metastatic Breast Cancer. Ann Oncol 2018 Apr; 29(4): 881-7. Epub 2018 Feb. (IF: 11.855; Oncology 10/217)

  5. Abou-Alfa G*, Qin S, Ryoo BY, Lu SN, Yen CJ, Feng YH, Lim HY, Izzo F, Colombo M, Sarker D, Bolondi L, Vaccaro G, Harris WP, Chen Z, Hubner RA, Meyer T, Sun W, Harding JJ, Hollywood EM, Ma J, Wan PJ, Ly M, Bomalaski J, Johnston A, Lin CC, Chao Y, Chen LT.  Phase III Randomized Study of Second Line ADI-PEG 20 Plus Best Supportive Care versus Placebo Plus Best Supportive Care in Patients with Advanced Hepatocellular Carcinoma. Ann Oncol 2018 Jun; 29(6): 1402-8. Epub 2018 Apr. (IF: 11.855; Oncology 10/217)

  6. Wu YL*, Lu S, Lu Y, Zhou J, Shi YK, Sriuranpong V, Ho JCM, Ong CK, Tsai CM, Chung CH, Wilner KD, Tang Y, Masters ET, Selaru P, Mok TS.  Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer. J Thorac Oncol 2018 Jun. [Epub ahead of print] (IF: 10.336; Oncology 11/222; Respiratory System 4/59)

  7. Chou YT, Jiang JK, Yang MH, Lu JW, Lin HK, Wang HD*, Yuh CH*.  Identification of a Noncanonical Function for Ribose-5-Phosphate Isomerase A Promotes Colorectal Cancer Formation by Stabilizing and Activating β-Catenin Via a Novel C-Terminal Domain. PLoS Biol 2018 Jan; 16(1): e2003714. (IF: 9.797; Biology 3/85; Biochemistry & Molecular Biology 15/290)

  8. Hsu PY, Wu VS, Kanaya N, Petrossian K, Hsu HK, Nguyen D, Schmolze D, Kai M, Liu CY, Lu H, Chu P, Vito CA, Kruper L, Mortimer J, Chen S*.  Dual mTOR Kinases MLN0128 Inhibitor Sensitizes HR+/HER2+ Breast Cancer Patient-Derived Xenografts to Trastuzumab or Fulvestrant. Clin Cancer Res 2018 Jan; 24(2): 395-406. Epub 2017 Oct. (IF: 9.619; Oncology 12/217)

  9. Chen HH, Yu HI, Yang MH, Tarn WY*.  DDX3 Activates CBC-eIF3-Mediated Translation of uORF-Containing Oncogenic mRNAs to Promote Metastasis in HNSCC. Cancer Res 2018 Aug; 78(16): 4512-23. Epub 2018 Jun. (IF: 9.130; Oncology 17/222)

  10. Hsu CY, Su YW, Chen SC*.  Sick Sinus Syndrome Associated with Anti-Programmed Cell Death-1. J Immunother Cancer 2018 Jul; 6(1): 72. (IF: 8.374; Oncology 18/222; Immunology 13/155)

  11. Yen CJ, Kim TY, Feng YH, Chao Y, Lin DY, Ryoo BY, Huang D CL, Schnell D, Hocke J, Loembe AB, Cheng AL*.  A Phase I/Randomized Phase II Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Nintedanib versus Sorafenib in Asian Patients with Advanced Hepatocellular Carcinoma. Liver Cancer 2018 May; 7(2): 165-78. Epub 2018 Mar. (IF: 7.854; Oncology 18/217; Gastroenterology & Hepatology 7/79)

  12. Huang CY, Hsieh FS*, Wang CY, Chen LJ, Chang SS, Tsai MH, Hung MH, Kuo CW, Shih CT, Chao TI, Chen KF*.  Palbociclib Enhances Radiosensitivity of Hepatocellular Carcinoma and Cholangiocarcinoma via Inhibiting Ataxia Telangiectasia-Mutated Kinase-Mediated DNA Damage Response. Eur J Cancer 2018 Aug; 102(): 10-22. (IF: 7.191; Oncology 25/222)

  13. Lin YC, Liu CY, Kannagi R, Yang RB*.  Inhibition of Endothelial SCUBE2 (Signal Peptide-CUB-EGF Domain-Containing Protein 2), a Novel VEGFR2 (Vascular Endothelial Growth Factor Receptor 2) Coreceptor, Suppresses Tumor Angiogenesis. Arterioscler Thromb Vasc Biol 2018 May; 38(5): 1202-15. Epub 2018 Mar. (IF: 6.607; Peripheral Vascular Disease 4/63; Hematology 6/70)

  14. Ahn MJ*, Tsai CM, Shepherd FA, Bazhenova L, Sequist LV, Hida T, Yang JCH, Ramalingam SS, Mitsudomi T, Janne PA, Mann H, Cantarini M, Goss G.  Osimertinib in Patients with T790M Mutation-Positive, Advanced Non-Small Cell Lung Cancer: Long-Term Follow-Up from a Pooled Analysis of 2 Phase 2 Studies. Cancer 2018 Dec. [Epub ahead of print] (IF: 6.537; Oncology 28/223)

  15. Chen YQ*, Kuo JC, Wei MT, Chen YC, Yang MH, Chiou A*.  Early Stage Mechanical Remodeling of Collagen Surrounding Head and Neck Squamous Cell Carcinoma Spheroids Correlates Strongly with Their Invasion Capability. Acta Biomater 2018 Nov. [Epub ahead of print] (IF: 6.383; Engineering, Biomedical 4/78; Materials Science, Biomaterials 3/33)

  16. Huang YH, Chu PY, Chen JL, Huang CT, Lee CH, Lau KY, Wang WL, Wang YL, Lien PJ, Tseng LM*, Liu CY*.  SET Overexpression is Associated with Worse Recurrence-Free Survival in Patients with Primary Breast Cancer Receiving Adjuvant Tamoxifen Treatment. J Clin Med 2018 Aug; 7(9): E245. (IF: 5.583; Medicine, General & Internal 15/154)

  17. Lee CY, Chen YW, Lee YY, Chang FC, Chen HH, Lin SC, Ming-Tak Ho D, Huang MC, Yen SH, Wong TT, Liang ML*.  Irradiation-Induced Secondary Tumors Following Pediatric Central Nervous System Tumors: Experiences of a Single Institute in Taiwan (1975-2013). Int J Radiat Oncol Biol Phys 2018 Aug; 101(5): 1243-52. Epub 2018 Apr. (IF: 5.554; Radiology, Nuclear Medicine & Medical Imaging 11/128; Oncology 40/222)

  18. Chen HY, Lin LT, Wang ML, Tsai KL, Huang PI, Yang YP, Lee YY, Chen YW, Lo WL, Lan YT, Chiou SH, Lin CM, Ma HI*, Chen MT*.  Musashi-1 Promotes Chemoresistant Granule Formation by PKR/eIF2α Signalling Cascade in Refractory Glioblastoma. Biochim Biophys Acta 2018 May; 1864(5 Pt A): 1850-61. Epub 2018 Feb. (IF: 5.476; Biophysics 9/72; Biochemistry & Molecular Biology 45/286)

  19. Liu CY, Hsu CC, Huang TT, Lee CH, Chen JL, Yang SH, Jiang JK, Chen WS, Lee KD, Teng HW*.  ER Stress-Related ATF6 Upregulates CIP2A and Contributes to Poor Prognosis of Colon Cancer. Mol Oncol 2018 Oct; 12(10): 1706-17. Epub 2018 Aug. (IF: 5.264; Oncology 46/222)

  20. Chiang CL, Wang LC, Ho HL, Tsai CM, Yeh YC, Hsu WH, Chou TY, Chiu CH*, Wu YC*.  Effect of Postoperative Systemic Therapy on Pulmonary Adenocarcinoma with Unexpected Pleural Spread Detected during Thoracotomy or Thoracoscopy. Oncotarget 2018 Jan; 9(4): 5435-44. Epub 2017 Dec. (IF: 5.168; Oncology 44/217; Cell Biology 48/189)

  21. Liang ML, Hsieh TH, Liu YR, Chen YW, Lee YY, Chang FC, Lin SC, Huang MC, Donald Ming-Tak H, Wong TT, Yen Y*, Yang MH*.  Significance of Cyclin D1 Overexpression in Progression and Radio-Resistance of Pediatric Ependymomas. Oncotarget 2018 Jan; 9(2): 2527-42. Epub 2017 Dec. (IF: 5.168; Oncology 44/217; Cell Biology 48/189)

  22. Kao YC, Fang WL, Wang RF, Li AF, Yang MH, Wu CW, Shyr YM, Huang KH*.  Clinicopathological Differences in Signet Ring Cell Adenocarcinoma between Early and Advanced Gastric Cancer. Gastric Cancer 2018 Aug. [Epub ahead of print] (IF: 5.045; Gastroenterology & Hepatology 13/80; Oncology 48/222)

  23. Hsieh CH, Tai SK, Yang MH*.  Snail-Overexpressing Cancer Cells Promote M2-Like Polarization of Tumor-Associated Macrophages by Delivering MiR-21-Abundant Exosomes. Neoplasia 2018 Aug; 20(8): 775-88. Epub 2018 Jul. (IF: 4.994; Oncology 49/222)

  24. Lin MC, Shueng PW, Chang WK, Mu-Hsin Chang P, Feng HC, Yang MH, Lou PJ*.  Consensus and Clinical Recommendations for Nutritional Intervention for Head and Neck Cancer Patients Undergoing Chemoradiotherapy in Taiwan. Oral Oncol 2018 Jun; 81(): 16-21. Epub 2018 Apr. (IF: 4.636; Dentistry, Oral Surgery & Medicine 3/91; Oncology 54/222)

  25. Hu MH, Huang TT, Chao TI, Chen LJ, Chen YL, Tsai MH, Liu CY*, Kao JH*, Chen KF*.  Serine/Threonine Protein Phosphatase 5 is a Potential Therapeutic Target in Cholangiocarcinoma. Liver Int 2018 May. [Epub ahead of print] (IF: 4.500; Gastroenterology & Hepatology 16/80)

  26. Chen YQ, Lan HY, Wu YC, Yang WH, Chiou A*, Yang MH*.  Epithelial-Mesenchymal Transition Softens Head and Neck Cancer Cells to Facilitate Migration in 3D Environments. J Cell Mol Med 2018 May. [Epub ahead of print] (IF: 4.499; Medicine, Research & Experimental 20/128; Cell Biology 60/190)

  27. Pai FY, Chen CJ, Wang WH, Yang HC, Lin CJ, Wu HM, Lin YC, Chen HS, Yen YS, Chung WY, Guo WY, Pan DH, Shiau CY, Lee CC*.  Low-Dose Gamma Knife Radiosurgery for Acromegaly. Neurosurgery 2018 Aug. [Epub ahead of print] (IF: 4.475; Surgery 12/200; Clinical Neurology 36/197)

  28. Murakami H*, Nokihara H, Hayashi H, Seto T, Park K, Azuma K, Tsai CM, Yang JC, Nishio M, Kim SW, Kiura K, Inoue A, Takeda K, Kang JH, Nakagawa T, Takeda K, Akazawa R, Kaneko Y, Shimazaki M, Morita S, Fukuoka M, Nakagawa K.  Clinical Activity of ASP8273 in Asian Patients with Non-Small Cell Lung Cancer with EGFR Activating and T790M Mutations. Cancer Sci 2018 Jul. [Epub ahead of print] (IF: 4.372; Oncology 65/222)

  29. Chang PM, Chen CH, Yeh CC, Lu HJ, Liu TT, Chen MH, Liu CY, Wu ATH, Yang MH, Tai SK, Mochly-Rosen D*, Huang CF*.  Transcriptome Analysis and Prognosis of ALDH Isoforms in Human Cancer. Sci Rep 2018 Feb; 8(1): 2713. (IF: 4.259; Multidisciplinary Sciences 10/64)

  30. Lee IC, Chao Y, Li CP, Su CW, Lan KH, Lin HC, Hou MC, Huang YH*.  Risk of Renal Events during Tenofovir Disoproxil Fumarate and Entecavir Antiviral Prophylaxis in HBsAg-Positive Cancer Patients Undergoing Chemotherapy. J Viral Hepat 2018 Aug. [Epub ahead of print] (IF: 4.237; Infectious Diseases 19/88; Gastroenterology &Amp; Hepatology 18/80; Virology 10/35)

  31. Kao RH, Lai GM, Chow JM, Liao CH, Zheng YM, Tsai WL, Hsia S, Lai IC, Lee HL, Chuang SE, Whang-Peng J, Yao CJ*.  Opposite Regulation of CHOP and GRP78 and Synergistic Apoptosis Induction by Selenium Yeast and Fish Oil via AMPK Activation in Lung Adenocarcinoma Cells. Nutrients 2018 Oct. [Epub ahead of print] (IF: 4.196; Nutrition & Dietetics 18/83)

  32. Chu YC, Kuo WT, Cheng YR, Lee CY, Shiau CY, Tarng DC, Lai F*.  A Survival Metadata Analysis Responsive Tool (SMART) for Web-Based Analysis of Patient Survival and Risk. Sci Rep 2018 Aug; 8(1): 12880. (IF: 4.122; Multidisciplinary Sciences 12/64)

  33. Lee PC, Chen YT, Chao Y, Huo TI, Li CP, Su CW, Lee MH, Hou MC, Lee FY, Lin HC, Huang YH*.  Validation of the ALBI Grade-Based Integrated Model as a Predictor for Sorafenib-Failed Hepatocellular Carcinoma. Liver Int 2018 Feb; 38(2): 321-30. Epub 2017 Aug. (IF: 4.116; Gastroenterology & Hepatology 17/79)

  34. Lee CC, Chen CJ, Chen SC, Yang HC, Lin CJ, Wu CC, Chung WY, Guo WY, Pan DHC, Shiau CY, Wu HM*.  Gamma Knife Surgery for Clival Epidural-Osseous Dural Arteriovenous Fistulas. J Neurosurg 2018 May; 128(5): 1364-71. Epub 2017 Jun. (IF: 4.059; Surgery 16/196; Clinical Neurology 39/194)

  35. Peng SJ, Lee CC, Wu HM, Lin CJ, Shiau CY, Guo WY, Pan DH, Liu KD, Chung WY, Yang HC*.  Fully Automated Tissue Segmentation of the Prescription Isodose Region Delineated through the Gamma Knife Plan for Cerebral Arteriovenous Malformation (AVM) Using Fuzzy C-Means (FCM) Clustering. Neuroimage Clin 2018 Nov. [Epub ahead of print] (IF: 3.869; Neuroimaging 3/14)

  36. Lee YY, Yarmishyn AA, Wang ML, Chen HY, Chiou SH, Yang YP, Lin CF, Huang PI, Chen YW, Ma HI*, Chen MT*.  MicroRNA-142-3p is Involved in Regulation of MGMT Expression in Glioblastoma Cells. Cancer Manag Res 2018 Apr; 10(): 775-85. (IF: 3.851; Oncology 72/217)

  37. Yeh CN*, Chen MH, Chang YC, Wu RC, Tsao LC, Wang SY, Cheng CT, Chiang KC, Chen TW, Hsiao M, Weng WH*.  Over-Expression of TNNI3K is Associated with Early-Stage Carcinogenesis of Cholangiocarcinoma. Mol Carcinog 2018 Oct. [Epub ahead of print] (IF: 3.851; Biochemistry & Molecular Biology 83/293; Oncology 79/223)

  38. Liu YM, Liu YK, Huang PI, Tsai TH*, Chen YJ*.  Antrodia Cinnamomea Mycelial Fermentation Broth Inhibits the Epithelial-Mesenchymal Transition of Human Esophageal Adenocarcinoma Cancer Cells. Food Chem Toxicol 2018 Sep; 119(): 380-6. Epub 2018 Feb. (IF: 3.778; Food Science & Technology 8/130; Toxicology 16/92)

  39. Huang CY, Hung MH*, Shih CT, Hsieh FS, Kuo CW, Tsai MH, Chang SS, Hsiao YJ, Chen LJ, Chao TI, Chen KF*.  Antagonizing SET Augments the Effects of Radiotherapy in Hepatocellular Carcinoma through Reactivating PP2A-Mediated AKT Downregulation. J Pharmacol Exp Ther 2018 Sep; 366(3): 410-21. Epub 2018 Jun. (IF: 3.706; Pharmacology & Pharmacy 53/261)

  40. Rau KM, Ou-Yang F, Chao TC, Kuo YL, Cheng TF, Chao TY, Chen DR, Tzeng YD, Wang BW, Liu CY, Hu MH, Lu YC, Ou WJ, Kuo CH, Chuang CH, Kan JY, Chen FM*, Hou MF*.  Effect of Eribulin on Patients with Metastatic Breast Cancer: Multicenter Retrospective Observational Study in Taiwan. Breast Cancer Res Treat 2018 Aug; 170(3): 583-91. Epub 2018 Apr. (IF: 3.626; Oncology 82/217)

  41. Muro K, Cho JY, Bodoky G, Goswami C, Chao Y, Dos Santos LV, Shimada Y, Topuzov E, Van Cutsem E, Tabernero J, Zalcberg J, Chau I, Cascinu S, Cheng R, Hsu Y, Emig M, Orlando M, Fuchs C*.  Age Does Not Influence Efficacy of Ramucirumab in Advanced Gastric Cancer: Subgroup Analyses of REGARD and RAINBOW. J Gastroenterol Hepatol 2018 Apr; 33(4): 814-24. Epub 2017 Sep. (IF: 3.452; Gastroenterology & Hepatology 27/79)

  42. Wu YL*, Sequist LV, Tan EH, Geater SL, Orlov S, Zhang L, Lee KH, Tsai CM, Kato T, Barrios CH, Schuler M, Hirsh V, Yamamoto N, O'Byrne K, Boyer M, Mok T, Peil B, Marten A, Chih-Hsin Yang J, Paz-Ares L, Park K.  Afatinib as First-line Treatment of Older Patients with EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials. Clin Lung Cancer 2018 Jul; 19(4): e465-79. Epub 2018 Mar. (IF: 3.434; Oncology 88/217)

  43. Wang TH, Liu CJ, Chao TF, Chen TJ, Hu YW*.  Second Primary Malignancy Risk after Radiotherapy in Rectal Cancer Survivors. World J Gastroenterol 2018 Oct; 24(40): 4586-95. (IF: 3.300; Gastroenterology & Hepatology 35/80)

  44. Tsai YF, Tseng LM, Lien PJ, Hsu CY*, Lin YS, King KL, Wang YL, Chao TC, Liu CY, Chiu JH, Yang MH.  HER2 Immunohistochemical Scores Provide Prognostic Information for Patients with HER2-Type Invasive Breast Cancer. Histopathology 2018 Dec. [Epub ahead of print] (IF: 3.267; Pathology 18/79; Cell Biology 99/190)

  45. Lee WP, Lan KL, Liao SX, Huang YH, Hou MC, Lan KH*.  Inhibitory Effects of Amentoflavone and Orobol on Daclatasvir-Induced Resistance-Associated Variants of Hepatitis C Virus. Am J Chin Med 2018 May; 46(4): 835-52. (IF: 3.222; Integrative & Complementary Medicine 3/26; Medicine, General & Internal 26/155)

  46. Cheng YJ, Tsai MH, Chiang CJ, Tsai ST, Liu TW, Lou PJ, Liao CT, Lin JC, Chang JT, Tsai MH, Chu PY, Leu YS, Tsai KY, Terng SD, Chien CY, Yang MH, Hao SP, Wang CC, Tsai MH, Chen HHW, Kuo C, Wu YH*.  Adjuvant Radiotherapy after Curative Surgery for Oral Cavity Squamous Cell Carcinoma and Treatment Effect of Timing and Duration on Outcome-A Taiwan Cancer Registry National Database Analysis. Cancer Med 2018 Jun. [Epub ahead of print] (IF: 3.202; Oncology 110/222)

  47. Lee CC*, Chou CL, Chen CJ, Yang HC, Wu HM, Shiau CY, Pan DH, Chung WY.  Stereotactic Radiosurgery for Hypervascular Intracranial Tumors. J Neurooncol 2018 Aug. [Epub ahead of print] (IF: 3.060; Clinical Neurology 78/197; Oncology 120/222)

  48. Cheng CT, Chen YY, Wu RC, Tsai CY, Chiang KC, Yeh TS, Chen MH*, Yeh CN*.  MET RON Dual Inhibitor, BMS 777607, Suppresses Cholangiocarcinoma Cell Growth, and MET RON Upregulation Indicates Worse Prognosis for Intra Hepatic Cholangiocarcinoma Patients. Oncol Rep 2018 Sep; 40(3): 1411-21. Epub 2018 Jul. (IF: 2.976; Oncology 123/222)

  49. Wang TH, Huang PI, Hu YW, Lin KH, Liu CS, Lin YY, Liu CA, Tseng HS, Liu YM, Lee RC*.  Combined Yttrium-90 Microsphere Selective Internal Radiation Therapy and External Beam Radiotherapy in Patients with Hepatocellular Carcinoma: From Clinical Aspects to Dosimetry. PLoS One 2018 Jan; 13(1): e0190098. (IF: 2.806; Multidisciplinary Sciences 15/64)

  50. Chen SC, Liao TT, Yang MH*.  Emerging Roles of Epithelial-Mesenchymal Transition in Hematological Malignancies. J Biomed Sci 2018 Apr; 25(1): 37. (IF: 2.799; Medicine, Research & Experimental 51/128; Cell Biology 111/190)

  51. Huang KH, Sung IC, Fang WL, Chi CW, Yeh TS, Lee HC, Yin PH, Li AF, Wu CW, Shyr YM, Yang MH*.  Correlation between HGF/c-Met and Notch1 Signaling Pathways in Human Gastric Cancer Cells. Oncol Rep 2018 Jul; 40(1): 294-302. Epub 2018 May. (IF: 2.662; Oncology 125/217)

  52. Lee JC, Chen YW, Chuang KS, Hsu FY, Chou FI, Hsu SM, Yen SH, Wu YH*.  The Dosimetric Impact of Shifts in Patient Positioning during Boron Neutron Capture Therapy for Brain Tumors. Biomed Res Int 2018 Oct; 2018(): 5826174. (IF: 2.583; Biotechnology & Applied Microbiology 64/160; Medicine, Research & Experimental 71/133)

  53. Xu ES, Yang MH, Liu CY, Liu KW, Yang TT, Chou TY*, Hwang TZ*, Hsu CT*.  Decreasing Cytokeratin 17 Expression in Head and Neck Cancer Predicts Nodal Metastasis and Poor Prognosis: the First Evidence. Clin Otolaryngol 2018 Mar. [Epub ahead of print] (IF: 2.523; Otorhinolaryngology 6/42)

  54. Hu LY, Liu CJ, Yeh CM, Lu T, Hu YW, Chen TJ, Chen PM, Lee SC, Chang CH*.  Depressive Disorders among Patients with Gastric Cancer in Taiwan: a Nationwide Population-Based Study. BMC Psychiatry 2018 Sep; 18(1): 272. (IF: 2.419; Psychiatry 71/142)

  55. Hung LT, Huang HI, Wang LW, Yang MH, Chu PY*.  Oncologic Results and Quality of Life in Patients with Squamous Cell Carcinoma of Hypopharynx after Transoral Laser Microsurgery. Lasers Surg Med 2018 Feb; 50(2): 117-24. Epub 2017 Oct. (IF: 2.312; Surgery 66/197; Dermatology 22/63)

  56. Xu ES, Yang MH, Huang SC, Liu CY, Yang TT, Chou TY*, Hwang TZ*, Hsu CT*.  ECE-1 Overexpression in Head and Neck Cancer is Associated with Poor Tumor Differentiation and Patient Outcome. Oral Dis 2018 Jul. [Epub ahead of print] (IF: 2.310; Dentistry, Oral Surgery & Medicine 21/91)

  57. Huang KH, Fang WL, Fen-Yau Li A, Liang PH, Wu CW, Shyr YM, Yang MH*.  Caspase-3, a Key Apoptotic Protein, as a Prognostic Marker in Gastric Cancer after Curative Surgery. Int J Surg 2018 Apr; 52(): 258-63. Epub 2018 Mar. (IF: 2.211; Surgery 72/197)

  58. Cappuzzo F*, Soo R, Hochmair M, Schuler M, Lam KC, Stehle G, Cseh A, Lorence RM, Linden S, Forman ND, Hilbe W, Jazieh AR, Tsai CM.  Global Named Patient Use Program of Afatinib in Advanced Non-Small-Cell Lung Carcinoma Patients Who Progressed Following Prior Therapies. Future Oncol 2018 Jun; 14(15): 1477-86. Epub 2018 Jan. (IF: 2.131; Oncology 153/217)

  59. Chang SC, Lai JI, Lu MC, Lin KH, Wang WS, Lo SS, Lai YC*.  Reduction in the Incidence of Pneumonia in Elderly Patients after Hip Fracture Surgery: An Inpatient Pulmonary Rehabilitation Program. Medicine (Baltimore) 2018 Aug; 97(33): e11845. (IF: 2.028; Medicine, General & Internal 56/154)

  60. Ho KY*, Ahn JS, Calimag MM, Chao TC, Kim YC, Moon H, Tho LM, Xia ZJ, You D.  Inadequate Treatment Practices for Pain Relief and Adverse Event Management in Cancer Patients Across 10 Countries/Regions in Asia: a Call for Greater Efforts to Improve Standards for Patient Care. Asia Pac J Clin Oncol 2018 Jun; 14(3): 159-66. Epub 2017 Jul. (IF: 1.959; Oncology 159/217)

  61. Chiang KC, Yeh CN, Yeh TS, Juang HH, Chen LW, Kuo SF, Chen MH, Chen TC, Takano M, Kittaka A*, Pang JS*.  MART-10, a 1α,25(OH)2D3 Analog, Potently Represses Metastasis of ER+ Breast Cancer Cells with VEGF-A Overexpression. Anticancer Res 2018 Jul; 38(7): 3879-87. (IF: 1.865; Oncology 182/222)

  62. Chang PM, Cheng CT, Wu RC, Chung YH, Chiang KC, Yeh TS, Liu CY, Chen MH, Chen MH*, Yeh CN*.  Nab-Paclitaxel is Effective against Intrahepatic Cholangiocarcinoma via Disruption of Desmoplastic Stroma. Oncol Lett 2018 Jul; 16(1): 566-72. Epub 2018 May. (IF: 1.664; Oncology 193/222)

  63. Chen JS*, Yeh CN, Cheng CT, Yen CC*, Chen YY, Huang SC, Chiang KC, Yeh TS, Chen SC, Chao TC, Yang MH, Chao Y.  Role of PLK1 Signaling Pathway Genes in Gastrointestinal Stromal Tumors. Oncol Lett 2018 Sep; 16(3): 3070-82. Epub 2018 Jun. (IF: 1.664; Oncology 193/222)

  64. Chen SC, Chang PM, Wang HJ, Tai SK, Chu PY*, Yang MH*.  PD-L1 Expression is Associated with p16INK4A Expression in Non-Oropharyngeal Head and Neck Squamous Cell Carcinoma. Oncol Lett 2018 Feb; 15(2): 2259-65. Epub 2017 Dec. (IF: 1.390; Oncology 192/217)

  65. Liu CH, Tseng YF, Lai JI, Chen YQ, Wang SH, Kao WF, Li LH, Chiu YH*, How CK, Chang WH.  The Changes of Red Blood Cell Viscoelasticity and Sports Anemia in Male 24-Hr Ultra-Marathoners. J Chin Med Assoc 2018 May; 81(5): 475-81. Epub 2017 Nov. (IF: 1.252; Medicine, General & Internal 82/154)

  66. Chiu HY, Lin LY, Chou WC, Fang WL, Shyr YM, Yeh YC, Mu-Hsin Chang P, Chen MH, Hung YP, Chao Y, Chien SH*, Chen MH.  Toxicities, Safeties and Clinical Response of Dacarbazine-Based Chemotherapy on Neuroendocrine Tumors in Taiwan Population. J Chin Med Assoc 2018 May; 81(5): 423-8. Epub 2017 Dec. (IF: 1.252; Medicine, General & Internal 82/154)

  67. Hung YP, Chen MH, Lin JS, Hsiao CF, Shan YS, Chen YC, Chen LT, Liu TW, Li CP, Chao Y*.  The Clinical Impact of the Novel Tumor Marker DR-70 in Unresectable Gastric Cancer Patients. J Chin Med Assoc 2018 Jul; 81(7): 593-8. Epub 2018 Apr. (IF: 1.252; Medicine, General & Internal 82/154)

  68. Lin ST, Wang TH, Shiau CY, Liu YM, Chen TJ*, Hu YW*.  整合多套放射腫瘤與醫療資訊系統以實現病歷電子化 Integration of Multiple Radiation Oncology and Health Information Systems to Implement Computerization of Medical Records. Therapeutic Radiology and Oncology 2018 Mar; 25(1): 21-32. (IF: -)

  69. Wang LW*, Liu YH, Chou FI, Jiang SH.  Clinical Trials for Treating Recurrent Head and Neck Cancer with Boron Neutron Capture Therapy Using the Tsing-Hua Open Pool Reactor. Cancer Commun (Lond) 2018 Jun; 38(1): 37. (IF: -)

  70. Yen CC, Chen TW*.  Next Frontiers in Systemic Therapy for Soft Tissue Sarcoma. Chin Clin Oncol 2018 Aug; 7(4): 43. (IF: -)

  71. Yen CJ, Muro K, Kim TW, Kudo M, Shih JY, Lee KW, Chao Y, Kim SW, Yamazaki K, Sohn J, Cheng R, Zhang Y, Binder P, Mi G, Orlando M, Chung HC*.  Ramucirumab Safety in East Asian Patients: A Meta-Analysis of Six Global, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trials. J Glob Oncol 2018 Jul. [Epub ahead of print] (IF: -)

  72. Kang YM, Lin SC, Lee YY, Chang FC, Liang ML, Chen HH, Liu YM, Wong TT, Chen YW*.  Treatment Outcomes for Pediatric Pineoblastoma: a Single Institute Experience in Taiwan. Therapeutic Radiology and Oncology 2018 Jul; 2: 27. (IF: -)

  73. Chung SY, Chen YH, Lin PR, Chao TC, Su JC, Shiau CW, Su Y*.  Two Novel SHP-1 Agonists, SC-43 and SC-78, are more Potent than Regorafenib in Suppressing the in Vitro Stemness of Human Colorectal Cancer Cells. Cell Death Discov 2018 Aug. [Epub ahead of print] (IF: -)